Hospital de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (34)

2023

  1. Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial

    Diabetes Care, Vol. 46, Núm. 1, pp. 206-208

  2. Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population

    The Journal of clinical endocrinology and metabolism, Vol. 108, Núm. 9, pp. 2193-2202

2020

  1. Effectiveness of sulfonylurea treatment in a patient with a mutation in ABCC8 (MODY12)

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 10, pp. 682-683

2019

  1. Dairy product consumption and metabolic diseases in the Di@bet.es study

    Nutrients, Vol. 11, Núm. 2

2018

  1. Consensus on insulin treatment in type 2 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 1-8

  2. Iron deficiency is associated with Hypothyroxinemia and Hypotriiodothyroninemia in the Spanish general adult population: Di@bet.es study

    Scientific Reports, Vol. 8, Núm. 1

  3. Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update

    Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 10, pp. 611-624

2017

  1. Population-Based National Prevalence of Thyroid Dysfunction in Spain and Associated Factors: Study

    Thyroid, Vol. 27, Núm. 2, pp. 156-166

  2. Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study

    Obesity, Vol. 25, Núm. 4, pp. 788-793

2016

  1. Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study

    PLoS ONE, Vol. 11, Núm. 8

  2. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578

2015

  1. Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice

    Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425

2014

  1. Ambient temperature and prevalence of obesity in the spanish population: The di@bet.es study

    Obesity, Vol. 22, Núm. 11, pp. 2328-2332

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863

  2. Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study

    Clinical Science, Vol. 124, Núm. 4, pp. 269-277

  3. Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study

    European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10

  4. Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: The Di@bet.es study

    Annals of Nutrition and Metabolism, Vol. 62, Núm. 4, pp. 339-346

  5. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

    European Journal of Clinical Nutrition, Vol. 67, Núm. 9, pp. 911-916